Subscribe to RSS - respiratory drugs

respiratory drugs

ASP: Budesonide takes a dive


BALTIMORE – Second quarter payments for respiratory drugs are up in most cases, with the exception of Budesonide (J7626), which decreased sharply, down nearly 73 cents per dose.

Mickey Letson's back in business.


A little over two years after he sold Letco, a high profile distributor of respiratory drugs and related products, to the Harvard Drug Group, he's running a technology company, Dream Software, and developing products intended to make HME providers more efficient.